Evidence map›Paper›PMID 36007896›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2022

5-Fluorouracil disrupts skeletal muscle immune cells and impairs skeletal muscle repair and remodeling.

Brandon N VanderVeen, Thomas D Cardaci, Sarah S Madero, Sierra J McDonald, Brooke M Bullard, Robert L Price, James A Carson, Daping Fan, E Angela Murphy

Open access · greenAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. TheToxicology reports · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Diversity in chemotherapy-induced cachexia.American journal of physiology. Cell physiology · 2025
    Review
  13. Involvement of the gut microbiota in cancer cachexia.American journal of physiology. Cell physiology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Gastric Cancer with Sarcopenia: an Area Worth Focusing On.Current treatment options in oncology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Brandon N VanderVeenDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina.ORCID 0000-0002-4535-0544
Thomas D CardaciDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina.
Sarah S MaderoDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina.
Sierra J McDonaldDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina.
Brooke M BullardDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina.
Robert L PriceCell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, South Carolina.
James A CarsonDepartment of Physical Therapy, College of Health Professions, University of Tennessee Health Science Center, Memphis, Tennessee.
Daping FanCell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, South Carolina.
E Angela MurphyDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina.ORCID 0000-0002-4803-5822
University of South Carolina · USUniversity of Tennessee Health Science Center · US

Funding

Development of Dietary Quercetin to Treat Muscle Wasting DisordersR43AT011171 · NCCIH · ACEPRE, LLC · PI VANDERVEEN, BRANDON, VELAZQUEZ, KANDY T · 2020 to 2021
$352k
NCCIH NIH HHS R43 AT011171USC | Office of the Vice President for Research, University of South Carolina ASPIRE-IIUSC | Office of the Vice President for Research, University of South Carolina ASPIRE-I Track IIb
6 · The paper itself

Abstract

5-Fluorouracil (5FU) remains a first-line chemotherapeutic for several cancers despite its established adverse side effects. Reduced blood counts with cytotoxic chemotherapies not only expose patients to infection and fatigue, but can disrupt tissue repair and remodeling, leading to lasting functional deficits. We sought to characterize the impact of 5FU-induced leukopenia on skeletal muscle in the context of remodeling. First, C57BL/6 mice were subjected to multiple dosing cycles of 5FU and skeletal muscle immune cells were assessed. Second, mice given 1 cycle of 5FU were subjected to 1.2% BaCl

Indexed as

FluorouracilMonocytesAnimalsMacrophagesMiceMice, Inbred C57BLMuscle, SkeletalFluorouracilchemotherapymacrophagesmonocytesmuscle repairskeletal muscle

Identifiers

PMID36007896
PMCPMC9529268
OpenAlexW4293237213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.